ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1932

Effects of Clinical Decision Support on Transition Readiness Assessment in Pediatric Rheumatology

Chrisana Pokorny1 and Bethany Marston2, 1University of Rochester, Webster, NY, 2University of Rochester, Rochester, NY

Meeting: ACR Convergence 2024

Keywords: informatics, Pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Health Services Research – ACR/ARP Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Pediatric to adult transition is often challenging among young adults with rheumatic diseases. Structured transition programs can improve adherence to care, quality of life, and disease-specific measures, although there has not been a clear correlation between transition readiness assessment scores and long-term success in the adult setting. The use of simplified documentation tools and prompts may address transition readiness more consistently during routine office visits. The “5 Rights” of clinical decision support include provision of the right information to the right person, in the right format, through the right channel, at the right time in the workflow.1 The pediatric rheumatology division at the University of Rochester Medical Center created and embedded a tool directly into EMR note templates to improve rates of assessment and documentation of patient readiness for transition.

Methods: A readiness tool was adapted from GotTransition2, with specific questions embedded into a tailored form targeted at each age group (12+, 14+, 16+, 18+) that displayed only for patients meeting age criteria. This tool was initially developed in 2017, and a direct link was embedded into standard specialty note templates in 2023. Use of each stage of the transition readiness questions was assessed by querying the EMR for encounters between 2018-2023, along with information about the documenting provider, the patient’s diagnosis codes, and the age of the patient at the time of documentation. 

Results: Use of the transition tool was greatest at the time of implementation, with gradual decline from 2019-2022 with high utilization again in 2023 after a restructure of the tool (Figure 1). Discussion of the transition policy was the most documented element (102 patients in 6 years) specific readiness elements, transition summary, and transfer planning were less frequently recorded (82%, 67%, and 58% respectively). The tool was not equally utilized across the practice; two providers (of eight) were responsible for most of the recorded elements, and documentation was more frequent in older vs. younger patients (Figure 1). Documentation of transition readiness was greater in those with juvenile idiopathic arthritis (JIA) (35%) and lupus (23%) than in patients with other diagnoses (18%).

Conclusion: The availability of an embedded documentation tool transiently improved routine documentation of transition readiness elements, and there was an increase in use with an updated implementation cycle. Documentation of transition discussions was greater in older patients and in those with some diagnoses (e.g. JIA and lupus) compared to others. Transition readiness elements were not documented consistently across age groups despite availability of clinical decision support. Understanding and developing other approaches to overcome barriers to addressing transition readiness are needed to help clinicians prepare patients for adult care.

Ref: 

<    1. Douthit B, et al. Real World Evidence: Clinical Decision Support: Definitions and Uses. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda MD: NIH Pragmatic Trials Collaboratory.

2     2. https://www.gottranstion.org/six-core-element1.

Supporting image 1

Figure 1: Use of the transition tool looking at documentation of specific elements of transition over time

Supporting image 2

Figure 2: Representation of total number of patients (upper pane) and percentage of those patients in which transition was discussed (lower pane) by diagnosis group and by age at the time of visit


Disclosures: C. Pokorny: None; B. Marston: None.

To cite this abstract in AMA style:

Pokorny C, Marston B. Effects of Clinical Decision Support on Transition Readiness Assessment in Pediatric Rheumatology [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/effects-of-clinical-decision-support-on-transition-readiness-assessment-in-pediatric-rheumatology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-clinical-decision-support-on-transition-readiness-assessment-in-pediatric-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology